RITUXIMAB-ARRX: 347 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
347
Total FAERS Reports
11 (3.2%)
Deaths Reported
21
Hospitalizations
347
As Primary/Secondary Suspect
7
Life-Threatening
6
Disabilities
Prescription
Status
FDA Application: 761140 ·
First Report: 20080101 · Latest Report: 20250908
What Are the Most Common RITUXIMAB-ARRX Side Effects?
#1 Most Reported
Product storage error
165 reports (47.6%)
#2 Most Reported
Circumstance or information capable of leading to medication error
116 reports (33.4%)
#3 Most Reported
Off label use
56 reports (16.1%)
All RITUXIMAB-ARRX Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 165 | 47.6% | 0 | 0 |
| Circumstance or information capable of leading to medication error | 116 | 33.4% | 0 | 0 |
| Off label use | 56 | 16.1% | 9 | 14 |
| Intercepted product administration error | 51 | 14.7% | 0 | 0 |
| Accidental exposure to product | 17 | 4.9% | 0 | 0 |
| Intercepted product preparation error | 16 | 4.6% | 0 | 0 |
| Fatigue | 14 | 4.0% | 6 | 8 |
| Infusion related reaction | 14 | 4.0% | 6 | 7 |
| Drug ineffective | 12 | 3.5% | 6 | 8 |
| Dyspnoea | 12 | 3.5% | 4 | 6 |
| Malaise | 12 | 3.5% | 4 | 5 |
| Pruritus | 12 | 3.5% | 4 | 5 |
| Drug intolerance | 10 | 2.9% | 6 | 8 |
| Rash | 10 | 2.9% | 5 | 6 |
| Rheumatoid arthritis | 9 | 2.6% | 6 | 8 |
| Dizziness | 8 | 2.3% | 4 | 6 |
| Hypertension | 8 | 2.3% | 6 | 6 |
| Pain | 8 | 2.3% | 4 | 6 |
| Systemic lupus erythematosus | 8 | 2.3% | 6 | 6 |
| Treatment failure | 8 | 2.3% | 4 | 7 |
Who Reports RITUXIMAB-ARRX Side Effects? Age & Gender Data
Gender: 60.6% female, 39.4% male. Average age: 57.0 years. Most reports from: US. View detailed demographics →
Is RITUXIMAB-ARRX Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 3 | 1 | 3 |
| 2019 | 1 | 0 | 0 |
| 2021 | 3 | 1 | 0 |
| 2022 | 14 | 0 | 0 |
| 2023 | 50 | 0 | 2 |
| 2024 | 51 | 0 | 5 |
| 2025 | 15 | 2 | 0 |
What Is RITUXIMAB-ARRX Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 247 |
| Rheumatoid arthritis | 15 |
| Off label use | 9 |
| Non-hodgkin's lymphoma | 8 |
| Immune thrombocytopenia | 7 |
| Lymphoma | 7 |
| Multiple sclerosis | 6 |
| Diffuse large b-cell lymphoma | 5 |
RITUXIMAB-ARRX vs Alternatives: Which Is Safer?
RITUXIMAB-ARRX vs RITUXIMAB-PVVR
RITUXIMAB-ARRX vs RIVAROXABAN
RITUXIMAB-ARRX vs RIVASTIGMINE
RITUXIMAB-ARRX vs RIVOTRIL
RITUXIMAB-ARRX vs RIZATRIPTAN
RITUXIMAB-ARRX vs ROACTEMRA
RITUXIMAB-ARRX vs ROCURONIUM
RITUXIMAB-ARRX vs ROFECOXIB
RITUXIMAB-ARRX vs ROFLUMILAST
RITUXIMAB-ARRX vs ROLAPITANT
Official FDA Label for RITUXIMAB-ARRX
Official prescribing information from the FDA-approved drug label.